ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00992745
Recruitment Status : Completed
First Posted : October 9, 2009
Last Update Posted : October 12, 2011
Sponsor:
Information provided by (Responsible Party):
Molecular Insight Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2011
  Actual Study Completion Date : September 2011